Literature DB >> 3954090

Pharmacokinetics of fentanyl in neonates.

D E Koehntop, J H Rodman, D M Brundage, M G Hegland, J J Buckley.   

Abstract

The pharmacokinetics of fentanyl were studied in fourteen neonates undergoing major surgical procedures. Five patients were less than 1 day of age, seven were 1-4 days old, and two were 7-14 days old. Fentanyl was given intravenously, 10 micrograms/kg (n = 1), 25 micrograms/kg (n = 4), or 50 micrograms/kg (n = 9), and plasma concentrations measured at intervals of up to 18 hr. Average weight was 2.9 kg. The injection of 25 or 50 micrograms/kg of fentanyl over 1-3 min was hemodynamically well-tolerated by all patients. Four newborns without respiratory impairment secondary to surgery or disease needed ventilatory support for an average of 24 hr (range 11-40 hr). Plasma concentrations of fentanyl were most appropriately described by a two-compartment model. The mean +/- SEM values of selected model parameters were volume of the central compartment, 1.45 +/- 0.34 L/kg; volume of distribution at steady state, 5.1 +/- 1 L/kg; clearance, 17.94 +/- 4.38 ml X kg-1 X min-1; and terminal elimination half-life (t 1/2 beta), 317 +/- 70 min. In seven patients transient rebound in plasma fentanyl concentrations of 0.5 ng/ml or greater occurred. In three patients with markedly increased intraabdominal pressure, the t 1/2 beta was 1.5-3 times the population mean. Thus fentanyl disposition in neonates is highly variable, but the t 1/2 beta is predictably prolonged in the presence of increased abdominal pressure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954090

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  41 in total

Review 1.  Assessment and management of pain in neonates.

Authors:  B J Stevens; L S Franck
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Common errors of drug administration in infants: causes and avoidance.

Authors:  B J Anderson; J F Ellis
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

3.  A Case Study Evaluating the Efficacy of an Ad Hoc Hospital Collection Device for Fentanyl in Infant Oral Fluid.

Authors:  Ashley M Gesseck; Justin L Poklis; Carl E Wolf; Jie Xu; Aamir Bashir; Karen D Hendricks-Muñoz; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2020-10-12       Impact factor: 3.367

4.  Fatal outcome in a child after ingestion of a transdermal fentanyl patch.

Authors:  Jörg Teske; Jens-Peter Weller; Klaus Larsch; Hans Dieter Tröger; Matthias Karst
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

5.  Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.

Authors:  E Jacqz-Aigrain; P Daoud; P Burtin; S Maherzi; F Beaufils
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 7.  New drugs and new understandings of paediatric pharmacology.

Authors:  D J Steward
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

8.  Continuous caudal anaesthesia with chloroprocaine as an adjunct to general anaesthesia in neonates.

Authors:  J D Tobias; G E Rasmussen; G W Holcomb; J W Brock; W M Morgan
Journal:  Can J Anaesth       Date:  1996-01       Impact factor: 5.063

9.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 10.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.